Printer Friendly
The Free Library
19,604,530 articles and books
Member login
User name  
Password 
 
Join us Forgot password?

BELLSYSTEM 24 Acquires Site Management Organization Business from Cell Product.


Tokyo Tokyo (tō`kēō), city (1990 pop. 8,163,573), capital of Japan and of Tokyo prefecture, E central Honshu, at the head of Tokyo Bay. , Japan, Jan 6, 2006 - (JCN JCN Japan Corporate News
JCN Journal of Cognitive Neuroscience
JCN Journal of Cardiovascular Nursing
JCN Journal of Christian Nursing
JCN Job Control Number
JCN Journal of Child Neurology
JCN joint communications network (US DoD) 
) - BELLSYSTEM 24 announced on January January: see month.  5 that it has established a new company BELL24 Cell Product in Hokkaido.

The company already took over site management organization (SMO SMO Server Management Objects
SMO SQL Management Objects
SMO Social Media Optimization
SMO Santa Monica Municipal Airport
SMO Sabhal Mòr Ostaig (Scotland Gaelic college)
SMO Site Management Organization
SMO Service Message Object
) operations from Hokkaido-based SMO company Cell Product on December 1, 2005.

Through these means, BELLSYSTEM 24 will fully enter the SMO market in Hokkaido, and plans to reinforce its SMO business with the aim of building a framework that will comprehensively support clinical trials, from phase 1 to 3.

Copyright [c] 2006 Japan Corporate News Network. All rights reserved.
COPYRIGHT 2006 Japan Corporate News Network K.K.
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2006, Gale Group. All rights reserved. Gale Group is a Thomson Corporation Company.

 Reader Opinion

Title:

Comment:



 

Article Details
Printer friendly Cite/link Email Feedback
Publication:JCNN News Summaries
Geographic Code:9JAPA
Date:Jan 7, 2006
Words:92
Previous Article:Nippon Shinyaku, INNOVIVE Pharmaceuticals Conclude Licensing Agreement for NS-187, Drug Candidate for Chronic Myelogenous Leukemia.
Next Article:Kagome to Launch Labre Lactobacillus-based Beverage in March.



Related Articles
SATCON TECHNOLOGY TO BUILD FUEL CELL POWER CONVERTERS - E- COMMERCE UTILITY.
Primary esophageal lymphoma: a diagnostic challenge in acquired immunodeficiency syndrome--two case reports and review.
Corporate takeovers in Japan: embracing grafting; Japan looks to adopt Western practices again.
BioMed brokerage enters the market with $7.7m Ewing buy.
Spindle-cell hemangioendothelioma of the posterior pharyngeal wall.
Cell phone technology and physical surveillance.
Toyota FCHV to Serve Centrair and Vicinity as Commercial Transport Vehicle.

Terms of use | Copyright © 2012 Farlex, Inc. | Feedback | For webmasters | Submit articles